The Lab Work Your Doctor Should Order Before (and During) GLP-1 Treatment

Why Lab Work Matters on GLP-1 Therapy

GLP-1 medications like semaglutide and tirzepatide affect multiple body systems beyond appetite. They influence blood sugar, kidney function, thyroid markers, liver enzymes, and nutrient absorption. Proper lab monitoring isn't about finding problems — it's about catching changes early and confirming that the treatment is doing what it should.

Unfortunately, not every provider orders the same baseline panel, and some skip ongoing monitoring altogether. This guide outlines what comprehensive lab monitoring looks like so you can advocate for appropriate testing.

Baseline Labs: Before Your First Dose

Before starting any GLP-1 medication, your provider should establish reference values that all future tests will be compared against. A thorough baseline panel typically includes:

Comprehensive Metabolic Panel (CMP) — This single blood draw covers kidney function (creatinine, BUN, eGFR), liver enzymes (ALT, AST), electrolytes (sodium, potassium, chloride), and fasting glucose. It's the foundation of your monitoring program.

Hemoglobin A1C — Even if you don't have diabetes, a baseline A1C establishes your blood sugar control. GLP-1 medications improve A1C, and tracking this change is one of the clearest measures of metabolic benefit.

Lipid Panel — Total cholesterol, LDL, HDL, and triglycerides. GLP-1 therapy often improves lipid profiles, particularly triglycerides. Having a baseline lets you quantify that improvement.

Thyroid Function (TSH and Free T4) — All GLP-1 medications carry a boxed warning about medullary thyroid carcinoma observed in rodent studies. While human risk remains uncertain, baseline thyroid values are essential — especially if you take levothyroxine, since GLP-1s can affect thyroid medication absorption.

Complete Blood Count (CBC) — General health assessment. Not directly related to GLP-1 therapy, but important for identifying any pre-existing issues before starting treatment.

Early Treatment Monitoring: 6-8 Weeks

The dose titration period (usually the first 2-3 months) is when side effects peak and your body adjusts. A check-in lab panel around 6-8 weeks helps catch any early organ stress.

At minimum, repeat the CMP (kidney and liver function) and check your A1C if you have diabetes or prediabetes. If you're on levothyroxine, check TSH at this point — oral semaglutide has been shown to increase levothyroxine exposure by up to 33%, which could shift your thyroid levels on a dose that's been stable for years.

If you've experienced significant nausea, vomiting, or diarrhea during titration, pay particular attention to kidney function markers. GLP-1 medications themselves aren't toxic to the kidneys, but dehydration from GI side effects can stress kidney function. An eGFR drop of more than 15 points from baseline warrants follow-up.

Ongoing Monitoring: Every 3-6 Months

Once you're on a stable dose, the monitoring interval depends on your overall health. For most patients without pre-existing conditions, testing every 6 months is reasonable. For patients with diabetes, kidney disease, or liver conditions, every 3 months is more appropriate.

The ongoing panel should include CMP, A1C (if relevant), and lipid panel. Thyroid function should be rechecked annually or if symptoms appear — fatigue, weight changes that don't match your medication response, or hair loss.

Symptom-Triggered Testing

Some labs should only be ordered if specific symptoms develop, not as routine screening:

• Amylase and lipase — Check only if persistent severe abdominal pain develops (pancreatitis concern). Routine pancreatic enzyme monitoring is not recommended for asymptomatic patients.
• Right upper quadrant ultrasound — If you develop right-sided abdominal pain, fever, or jaundice. Gallstones are associated with rapid weight loss, not the medication itself.
• Vitamin B12, iron, ferritin — If you develop fatigue, hair shedding, or significantly reduced dietary intake over several months.

What to Watch For Between Lab Draws

Lab tests don't replace symptom awareness. Contact your provider promptly if you experience persistent severe abdominal pain that radiates to the back, unusual fatigue that doesn't improve with rest, swelling in your neck or difficulty swallowing, changes in urination patterns or leg swelling, or persistent rapid heart rate.

How to Advocate for Proper Monitoring

If your provider hasn't ordered baseline labs before prescribing a GLP-1, ask for them. A simple conversation starter: "I'd like to get a comprehensive metabolic panel and thyroid function checked before I start — can we order those?" Most providers will readily agree.

For ongoing monitoring, keep your own record of lab results. Many patient portals make this easy. Tracking trends over time — watching your A1C improve, your lipids shift, your kidney function stay stable — gives you concrete evidence that the treatment is working and doing so safely.

If cost is a barrier, discuss with your provider which tests are most critical. A CMP and A1C are generally the minimum. Comprehensive panels can often be ordered through direct-to-consumer lab services at lower cost than through insurance.